Kakimoto Kenichi
The Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Hinyokika Kiyo. 2012 Dec;58(12):727-30.
Extragonadal germ cell tumors (EGGCT) are very rare and account for only 2% to 5% of all malignant germ cell neoplasms. Although multimodality treatment, including cisplatin-based chemotherapy and postchemotherapy surgery, has improved the prognosis of patients with EGGCT, few findings are available for these tumors. This article presents the clinical outcome and management of EGGCT patients.
性腺外生殖细胞肿瘤（EGGCT）非常罕见，仅占所有恶性生殖细胞肿瘤的2%至5%。尽管包括以顺铂为基础的化疗和化疗后手术在内的多模式治疗改善了EGGCT患者的预后，但关于这些肿瘤的研究发现却很少。本文介绍了EGGCT患者的临床结局和治疗情况。
